| Literature DB >> 33000521 |
Hatice Ünver1, Ayşe Rodopman Arman2, Ayşe Burcu Erdoğdu2, Çağla İlbasmış2.
Abstract
Entities:
Mesh:
Year: 2020 PMID: 33000521 PMCID: PMC7537180 DOI: 10.1111/pcn.13160
Source DB: PubMed Journal: Psychiatry Clin Neurosci ISSN: 1323-1316 Impact factor: 12.145
Summary of each case's background characteristics and clinical findings
| Case 1 | Case 2 | Case 3 | |
|---|---|---|---|
| Age (years)/sex/diagnosis | 13/female/anorexia nervosa | 16/female/anorexia nervosa | 16/female/anorexia nervosa |
| Bodyweight (kg) | 40 | 37 | 40 |
| Body mass index (kg/m2) | 14.3 | 14.1 | 15.2 |
| Disease duration | 8 weeks | 6 weeks | 8 weeks |
| Weight loss | 20 kg in 4 weeks | 10 kg in 4 weeks | 15 kg in 8 weeks |
| Premorbid psychiatric history | None | None | None |
| Follow‐up in inpatient unit | 1 day in pediatric emergency unit | 10 days in pediatric inpatient unit | 2 days in pediatric emergency unit |
| Comorbid psychiatric disease | Major depressive disorder | Major depressive disorder | Anxiety disorder |
| Amenorrhea | + | + | + |
| Psychiatric medication | Olanzapine 10 mg/day + fluoxetine 20 mg/day | Olanzapine 5 mg/day + fluoxetine 20 mg/day | Olanzapine 5 mg/day + sertraline 50 mg/day |
|
| |||
| Fasting blood glucose (mg/dL) | 62 | 65 | 53 |
| Na/K (mEq/L) | 138/4.4 | 135/4.0 | 135/4.4 |
| AST/ALT (U/L) | 24/18 | 32/20 | 41/21 |
| BUN/Cr (mg/dL) | 6/0.76 | 8/0.80 | 14/0.84 |
| WBC (×103/μL) | 3.6 | 5.0 | 4.6 |
| Hgb (g/dL) | 13.9 | 12.5 | 15.1 |
| Plt (×103/μL) | 214 | 270 | 224 |
| Heart rate (b.p.m.) | 60 | 62 | 45 |
Laboratory reference values: fasting blood glucose, 65–110 mg/dL; ALT, 10–40 U/L; AST, 10–37 U/L; BUN, 5–18 mg/dL; Cr, 0–1.2 mg/dL; Hgb, 12.0–17.0 g/dL; K, 3.5–5.3 mEq/L; Na, 136–146 mEq/L; Plt, 150.0–440.0 ×103/μL; WBC, 4.0–10.0 ×103/μL; heart rate, 60–100 b.p.m.
ALT, alanine aminotransferase; AST, aspartate aminotransferase; BUN, blood urea nitrogen; Cr, creatinine; Hgb, hemoglobin; K, potassium; Na, sodium; Plt, platelets; WBC, white blood cells.